217 related articles for article (PubMed ID: 12865319)
1. Functional characterization of W147A: a high-affinity interleukin-11 antagonist.
Underhill-Day N; McGovern LA; Karpovich N; Mardon HJ; Barton VA; Heath JK
Endocrinology; 2003 Aug; 144(8):3406-14. PubMed ID: 12865319
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-11 signals through the formation of a hexameric receptor complex.
Barton VA; Hall MA; Hudson KR; Heath JK
J Biol Chem; 2000 Nov; 275(46):36197-203. PubMed ID: 10948192
[TBL] [Abstract][Full Text] [Related]
3. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
[TBL] [Abstract][Full Text] [Related]
4. Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions.
Dahmen H; Horsten U; Küster A; Jacques Y; Minvielle S; Kerr IM; Ciliberto G; Paonessa G; Heinrich PC; Müller-Newen G
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):695-702. PubMed ID: 9560294
[TBL] [Abstract][Full Text] [Related]
5. Mediation of interleukin-11-dependent biological responses by a soluble form of the interleukin-11 receptor.
Karow J; Hudson KR; Hall MA; Vernallis AB; Taylor JA; Gossler A; Heath JK
Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):489-95. PubMed ID: 8809037
[TBL] [Abstract][Full Text] [Related]
6. Identification of three distinct receptor binding sites of murine interleukin-11.
Barton VA; Hudson KR; Heath JK
J Biol Chem; 1999 Feb; 274(9):5755-61. PubMed ID: 10026196
[TBL] [Abstract][Full Text] [Related]
7. A fusion protein of interleukin-11 and soluble interleukin-11 receptor acts as a superagonist on cells expressing gp130.
Pflanz S; Tacken I; Grötzinger J; Jacques Y; Minvielle S; Dahmen H; Heinrich PC; Müller-Newen G
FEBS Lett; 1999 Apr; 450(1-2):117-22. PubMed ID: 10350068
[TBL] [Abstract][Full Text] [Related]
8. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
[TBL] [Abstract][Full Text] [Related]
9. IL-11 activates human endothelial cells to resist immune-mediated injury.
Mahboubi K; Biedermann BC; Carroll JM; Pober JS
J Immunol; 2000 Apr; 164(7):3837-46. PubMed ID: 10725745
[TBL] [Abstract][Full Text] [Related]
10. Recombinant soluble interleukin-11 (IL-11) receptor alpha-chain can act as an IL-11 antagonist.
Curtis DJ; Hilton DJ; Roberts B; Murray L; Nicola N; Begley CG
Blood; 1997 Dec; 90(11):4403-12. PubMed ID: 9373251
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma.
Campbell CL; Jiang Z; Savarese DM; Savarese TM
Am J Pathol; 2001 Jan; 158(1):25-32. PubMed ID: 11141475
[TBL] [Abstract][Full Text] [Related]
12. Astrocyte differentiation of fetal neuroepithelial cells by interleukin-11 via activation of a common cytokine signal transducer, gp130, and a transcription factor, STAT3.
Yanagisawa M; Nakashima K; Arakawa H; Ikenaka K; Yoshida K; Kishimoto T; Hisatsune T; Taga T
J Neurochem; 2000 Apr; 74(4):1498-504. PubMed ID: 10737606
[TBL] [Abstract][Full Text] [Related]
13. Functional expression of the interleukin-11 receptor alpha-chain and evidence of antiapoptotic effects in human colonic epithelial cells.
Kiessling S; Muller-Newen G; Leeb SN; Hausmann M; Rath HC; Strater J; Spottl T; Schlottmann K; Grossmann J; Montero-Julian FA; Scholmerich J; Andus T; Buschauer A; Heinrich PC; Rogler G
J Biol Chem; 2004 Mar; 279(11):10304-15. PubMed ID: 14701802
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators?
Auernhammer CJ; Kopp FB; Vlotides G; Dorn F; Isele NB; Spöttl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
Neuroimmunomodulation; 2004; 11(4):224-32. PubMed ID: 15249728
[TBL] [Abstract][Full Text] [Related]
15. Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric IL-6.receptor complex.
Ward LD; Hammacher A; Howlett GJ; Matthews JM; Fabri L; Moritz RL; Nice EC; Weinstock J; Simpson RJ
J Biol Chem; 1996 Aug; 271(33):20138-44. PubMed ID: 8702737
[TBL] [Abstract][Full Text] [Related]
16. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase.
Giordano V; De Falco G; Chiari R; Quinto I; Pelicci PG; Bartholomew L; Delmastro P; Gadina M; Scala G
J Immunol; 1997 May; 158(9):4097-103. PubMed ID: 9126968
[TBL] [Abstract][Full Text] [Related]
17. Analysis of IL-6-mediated growth control of myeloma cells using a gp130 chimeric receptor approach.
French JD; Tschumper RC; Jelinek DF
Leukemia; 2002 Jun; 16(6):1189-96. PubMed ID: 12040452
[TBL] [Abstract][Full Text] [Related]
18. Negative cross-talk between interleukin-3 and interleukin-11 is mediated by suppressor of cytokine signalling-3 (SOCS-3).
Magrangeas F; Boisteau O; Denis S; Jacques Y; Minvielle S
Biochem J; 2001 Jan; 353(Pt 2):223-30. PubMed ID: 11139384
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C delta associates with the interleukin-6 receptor subunit glycoprotein (gp) 130 via Stat3 and enhances Stat3-gp130 interaction.
Novotny-Diermayr V; Zhang T; Gu L; Cao X
J Biol Chem; 2002 Dec; 277(51):49134-42. PubMed ID: 12361954
[TBL] [Abstract][Full Text] [Related]
20. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells.
Bellido T; Stahl N; Farruggella TJ; Borba V; Yancopoulos GD; Manolagas SC
J Clin Invest; 1996 Jan; 97(2):431-7. PubMed ID: 8567964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
